HIMS & HERS HEALTH INC (HIMS) Stock Analyst Earnings Estimates
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 271.878M | 526.916M 93.81% | 872M 65.49% | 1.495B 71.44% | 2.098B 40.33% | 2.419B 15.30% | 2.986B 23.44% | 3.576B 19.76% | 4.592B 28.41% | 5.44B 18.47% | 6.348B 16.69% | 7.285B 14.76% | |
| EBITDA YoY % growth | -97.643M -525.31% | -58.904M 39.67% | -16.493M 72.00% | 174.39M 1,157.36% | 260.43M 49.34% | 321.09M 23.29% | 356.75M 11.11% | 472.87M 32.55% | 466.55M -1.34% | 534.38M 14.54% | 609.55M 14.07% | 692.38M 13.59% | |
| EBIT YoY % growth | -101.718M -2,022.66% | -66.378M 34.74% | -26.008M 60.82% | 70.657M 371.67% | 140.79M 99.26% | 181.01M 28.57% | 241.15M 33.22% | 334.46M 38.69% | 340.68M 1.86% | 450.84M 32.34% | 561M 24.43% | N/A | |
| Operating Margin | -37.41% | -12.60% | -2.98% | 4.73% | 6.71% | 7.48% | 8.08% | 9.35% | 7.42% | 8.29% | 8.84% | N/A | |
| EPS YoY % growth | -0.56 -98.33% | -0.32 42.75% | -0.11 65.63% | 0.56 608.15% | 0.55 -1.57% | 0.73 31.88% | 1.31 80.63% | 1.46 11.28% | 1.71 17.48% | 1.99 16.07% | 2.31 15.90% | 2.65 15.04% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.11 1,001.60% | 0.13 168.61% | 0.15 149.34% | 0.16 -51.13% | 0.17 54.32% | 0.23 74.68% | 0.22 46.59% | 0.18 17.39% | 0.18 5.00% |
| Revenue Q2Q % growth | 478.72M 94.47% | 507.42M 82.41% | 529.75M 67.83% | 522.56M 30.13% | 543.47M 13.53% | 523.99M 3.27% | 532.4M 0.50% | 537.89M 2.93% | 552.43M 1.65% |
| EBITDA Q2Q % growth | 55.211M 473.80% | 59.745M 363.00% | 66.703M 264.44% | 68.781M 100.77% | 72.852M 31.95% | 76.765M 28.49% | 77.961M 16.88% | 74.523M 8.35% | 75.146M 3.15% |
| EBIT Q2Q % growth | 28.763M 26,781.31% | 34.505M 248.43% | 40.868M 250.53% | 40.325M 73.58% | 43.411M 50.93% | 52.16M 51.17% | 50.843M 24.41% | 44.667M 10.77% | 44.122M 1.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 239.41% | 0% | 138.26% |
| Revenue | 0% | 41.04% | 0.07% | 5.43% |